• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Immunological Pathogenesis of Sepsis & Use of Hemosorption for Treatment of Cancer Patients with Sepsis

Immunological Pathogenesis of Sepsis & Use of Hemosorption for Treatment of Cancer Patients with Sepsis

9781629486741
314,94 zł
283,44 zł Zniżka 31,50 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 283,44 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
This monograph summarizes the data of the prospective study on the immunological characteristics of cancer patients with sepsis and septic shock developed after surgery. Patients without signs of infectious complications and symptoms of organ failure, as well as a group of healthy donors, were considered as references. The comparative analysis of blood parameters that characterized humoural and cell immunity (concentrations of cytokines and their receptors, immunoglobulins, lipopolysaccharide and other active biomolecules) has been performed. An estimation of diagnostic and prognostic significances of these parameters has been performed as well. In the final chapters, the properties of the new perspective hypercrosslinked polymeric hemosorbents are presented. The monograph could be interesting for a wide array of specialists in the fields of resuscitation, healthcare therapy, oncology and surgery, as well as for researchers aimed toward the development of new types of biocompatible materials.
Szczegóły produktu
74452
9781629486741
9781629486741

Opis

Rok wydania
2014
Numer wydania
1
Oprawa
twarda
Liczba stron
100
Wymiary (mm)
155.00 x 230.00
Waga (g)
342
  • Introduction; Immunological Pathogenesis of Sepsis:: Diagnostic & Prognostic Markers of Sepsis; Pathomorphology of Sepsis; Use of Hemosorption in Treatment of Cancer Patients:: Effectiveness of Different Devices; Detoxification of Blood & Plasma by Means of Hypercrosslinked Polymeric Hemosorbents:: State-of-the-Art; An Experience of Application of the Device Based on the Hemosorbent Styrosorb 514 in Treatment of Dogs with Sepsis (Pilot Study); Conclusion.
Komentarze (0)